Skip to main content

Clinical trial I7W-MC-JQBA

A Phase 1 Study of LY3127804 as Monotherapy and in Combination with Ramucirumab in Patients with Advanced Solid Tumors

Organ Multiple
Trial status Trial closed
Trial type
Interventional with experimental drug
Phase Trial phase 1
Academic trial Non
Sponsor Lilly
EudraCT Identifier 2015-001204-64
Inclusion criteria RECIST 1.1 after standard trerapy
Last update